T38.7X Poisoning by, adverse effect of and underdosing of androgens and anabolic congeners

Name of the Condition

• Poisoning by, adverse effect of and underdosing of androgens and anabolic congeners

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to androgens and anabolic congeners. These substances are used for therapeutic purposes, such as hormone replacement or anabolic effects, and the code covers scenarios where their use leads to harmful outcomes or insufficient therapeutic effect.

Causes

The causes include accidental or intentional overdose of androgens or anabolic agents, adverse reactions to prescribed or non-prescribed use, or inadequate dosing that fails to achieve the intended therapeutic effect. Underdosing may result from missed doses, incorrect administration, or subtherapeutic prescribing.

Risk Factors

• Use of androgen or anabolic therapies for medical conditions
• Polypharmacy involving androgenic agents
• Incorrect dosing or administration
• Individual sensitivity to androgenic substances
• Renal or hepatic impairment affecting drug metabolism

Symptoms

Symptoms vary based on the specific agent and scenario: poisoning may cause virilization (e.g., hirsutism, voice deepening), electrolyte imbalances, or cardiovascular effects; adverse effects can include hepatotoxicity or mood changes; underdosing may lead to inadequate therapeutic response for conditions like hypogonadism.

Diagnosis

Diagnosis relies on a thorough medication history, clinical assessment of symptoms, and laboratory testing to evaluate hormone levels or toxic effects. Documentation should specify the substance involved and the nature of the event (poisoning, adverse effect, or underdosing).

Treatment Options

Treatment depends on the severity and type of event. For poisoning, supportive care and discontinuation of the agent may be necessary. Adverse effects may require dose adjustment or alternative therapy. Underdosing is addressed by optimizing dosing regimens. Specific interventions are guided by clinical presentation and patient factors.

Prognosis and Follow-Up

Prognosis varies based on the extent of exposure, underlying health, and timely intervention. Follow-up involves monitoring for resolution of symptoms, adjustment of therapy, and evaluation of long-term effects, particularly with chronic use or high-dose exposure.

Complications

Complications may include organ damage (e.g., liver toxicity), endocrine disturbances, cardiovascular issues, or psychological effects. Severe poisoning or prolonged underdosing can lead to persistent health problems.

Lifestyle & Prevention

Prevention focuses on proper medication use, adherence to prescribed dosing, and avoiding non-prescribed androgenic agents. Patients should be educated on signs of adverse effects or underdosing and the importance of regular monitoring.

When to Seek Professional Help

Seek immediate medical attention for symptoms of poisoning (e.g., severe virilization, organ dysfunction) or if adverse effects are severe or persistent. Consult a healthcare provider for concerns about underdosing or inadequate therapeutic response.

Tips for Medical Coders

Document the specific androgen or anabolic congener involved, the nature of the event (poisoning, adverse effect, or underdosing), and any contributing factors (e.g., incorrect dosing, non-adherence). Ensure clinical details support the coded scenario to accurately reflect the patient’s condition.